Historical record - last NADAC effective date: 12/19/2018
Product Information
BROMOCRIPTINE 5 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $5.4547 per EA under NDC 68382011001. Its NADAC has been published 256 times since Feb 19, 2014.
FDA first approved this application on Jul 30, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382011001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
12/19/2018
Active Ingredients
BROMOCRIPTINE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA078899FDA Approved
7/30/2008
TE Code
AB
On Market Since
1/23/2009
Pharmacological Classes
Price Statistics
The NADAC for BROMOCRIPTINE 5 MG CAPSULE has been published 256 times since Feb 19, 2014, and over the history we have for it it has declined 22.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.4547 per EA |
|---|---|
| All-time high | $6.9950 (Jul 16, 2014) |
| All-time low | $5.4547 (Dec 19, 2018) |
| Median price | $6.1198 |
| Average price | $6.1551 |
| Largest weekly change | -17.0% (Jul 23, 2014) |
| Weeks tracked | 256 |
| Tracking since | Feb 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-22.0%
Last surveyed Feb 6, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BROMOCRIPTINE 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BROMOCRIPTINE 5 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $5.4547 per EA (NDC 68382011001), effective Feb 6, 2019.
How has the price of BROMOCRIPTINE 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BROMOCRIPTINE 5 MG CAPSULE has declined 22.0%. It has been tracked across 256 weekly CMS publications since Feb 19, 2014.
What are the highest and lowest recorded NADAC prices for BROMOCRIPTINE 5 MG CAPSULE?
Since Feb 19, 2014, the NADAC for BROMOCRIPTINE 5 MG CAPSULE has ranged from a low of $5.4547 (Dec 19, 2018) to a high of $6.9950 (Jul 16, 2014), with a median of $6.1198 per EA.
Are there cheaper alternatives to BROMOCRIPTINE 5 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BROMOCRIPTINE 5 MG CAPSULE, is $4.1167 per EA — about 25% below BROMOCRIPTINE 5 MG CAPSULE.
Who manufactures BROMOCRIPTINE 5 MG CAPSULE?
BROMOCRIPTINE 5 MG CAPSULE (NDC 68382011001) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.